NCI Corner

Articles from the US National Cancer Institute about issues relevant to the field of thoracic oncology.

Discussing ALCHEMIST with Dr. Shakun Malik

Posted: December 2017 Patients with completely resected early-stage non-small cell lung cancer (NSCLC) have approximately a 50% chance of experiencing disease recurrence following standard treatment....

NCI Selects Five Teams of Researchers to Expand Discovery of Predictive Biomarkers for Immunotherapy

Posted: August 2018 In October 2017, the United States National Cancer Institute (NCI) launched a major effort to expand the discovery and validation of predictive...

NCI Corner – Interview with Shakun Malik, MD

By Erik J. Mac Laren, PhD In late 2015, the US National Cancer Institute (NCI) Thoracic Malignancy Steering Committee (TMSC) published its strategic priorities for...

NCI Corner: Racial Differences in the Transcriptomes of Lung Tumors

Posted: December 2018 Investigators at the National Cancer Institute (NCI) compared the transcriptional profiles of lung cancers from African American patients to those from white...

Small Cell Lung Cancer: The Next Challenge

By Peter Ujhazy, MD, PhD The newfound optimism in the management of lung cancer that infused the research, clinical, and patient communities 12 years ago...

NCI Director Dr. Norman E. Sharpless Discusses 2019 Budget Plans During Social Media Event

By Erik MacLaren, PhD Posted: April 1, 2019 On January 25, 2019, the Director of the National Cancer Institute (NCI) Norman E. Sharpless, MD, participated in a...

NCI Corner – Interview with Dinah S. Singer, PHD

By Erik J. MacLaren, PhD Blue Ribbon Panel of the US National Cancer Advisory Board During his State of the Union address in January 2016, President...

Lung Cancer and Smoking Cessation: Opportunities for Progress

By Stephanie R. Land, PhD Tobacco cessation assistance, imperative for tobacco users who seek medical care,1 takes on even greater urgency for individuals who are...

Tools for Smoking Cessation

By Erik J. MacLaren, PhD Posted: October 2017 Scott Gottlieb, MD, Commissioner of the U.S. Food and Drug Administration, said in a recent speech, “There’s probably...

Meeting News